Combining CAR-T cells and inhibitor drugs for high-risk neuroblastoma

Chimeric antigen receptor (CAR)-T cell therapy is a potent emerging weapon against cancer, altering patients’ T cells so they can better find and destroy tumor cells. But CAR-T cell therapy doesn’t work well in every cancer—including many cases of neuroblastoma, a cancer that begins in young children’s nerve tissue and can metastasize to multiple areas of the body.

Report shows score comparability in-person, remote proctoring

Residents taking the 2020 Internal Medicine In-Training Examination (IM-ITE) performed similarly across in-person and remote proctoring—providing evidence of score comparability, according to an American College of Physicians (ACP) research report, “A Comparison of Remote vs. In-Person Proctored In-Training Examination Administration for Internal Medicine”, published in Academic Medicine.